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Self management of arthritis in primary care: randomised
controlled trial
Marta Buszewicz, Greta Rait, Mark Griffin, Irwin Nazareth, Anita Patel, Angela Atkinson, Julie Barlow, Andy Haines
Abstract
Objective To evaluate clinical effectiveness of a self
management programme for arthritis in patients in primary
care with osteoarthritis.
Design Randomised controlled trial.
Setting 74 general practices in the United Kingdom.
Participants 812 patients aged 50 and over with osteoarthritis
of hips or knees (or both) and pain or disability (or both).
Intervention Participants were randomised to six sessions of
self management of arthritis and an education booklet
(intervention group) or the education booklet alone (control
group).
Main outcome measures Primary outcome was quality of life,
as assessed by the short form health survey (SF-36). Several
other physical and psychosocial secondary outcomes were
assessed. Data were collected at baseline, four months, and 12
months.
Results Response rates were 80% and 76% at four and 12
months. The two groups showed significant differences at 12
months on the anxiety subscore of the hospital anxiety and
depression scale (mean difference − 0.62, 95% confidence
interval − 1.08 to − 0.16), arthritis self efficacy scale for pain
(0.98, 0.07 to 1.89), and self efficacy for other aspects of
management (1.58, 0.25 to 2.90). Results were similar for
intention to treat and per protocol analyses. No significant
difference was seen in number of visits to the general
practitioner at 12 months.
Conclusions The self management of arthritis programme
reduced anxiety and improved participants’ perceived self
efficacy to manage symptoms, but it had no significant effect on
pain, physical functioning, or contact with primary care.
Trial registration Current Controlled Trials
ISRCTN79115352.
Introduction
Osteoarthritis is a common chronic disease associated with age-
ing and a major worldwide problem for medical, psychosocial,
and economic reasons.1 At least five million UK adults (8% of the
population) have moderate to severe osteoarthritis.2 Affected
people are mainly cared for in the community.
Osteoarthritis leads to considerable morbidity in terms of
pain, functional disability, lowered quality of life, and psychologi-
cal problems.1 Patient centred programmes for self management
of arthritis, tested in the United States on volunteers from the
community with osteoarthritis and rheumatoid arthritis, had
beneficial effects on pain, depression, exercise taken, communi-
cation with doctors, and participants’ perception of their capac-
ity to manage the disease (arthritis self efficacy).3 Similar results
were found in studies on volunteers in the UK.4 A review
commissioned by the Department of Health suggested that self
management can improve knowledge, performance of self man-
agement behaviours, self efficacy, and aspects of health status
compared with standard care, but the studies reviewed had small
sample sizes and short follow-up, and they used non-validated
outcome measures.5
A recent US randomised controlled trial of participants from
primary care with osteoarthritis, rheumatoid arthritis, or
fibromyalgia recruited to programmes for self management of
arthritis showed no difference in any outcomes measured
(disability, pain, self efficacy, mental health, and satisfaction) at
four months.6 This was a small study of 178 subjects, however,
and highlights the need for a large well designed randomised
trial in primary care. This is relevant to the UK government’s
promotion of the expert patient programme in primary care set-
tings, a generic self management programme for people with a
variety of chronic diseases (www.expertpatients.nhs.uk/), devel-
oped from the arthritis self management programme. We
hypothesised that for primary care patients with osteoarthritis,
participation in an arthritis self management programme and
receipt of an educational booklet would improve their overall
function compared with receipt of the booklet alone.
Methods
Practices
People with osteoarthritis were recruited from UK general prac-
tices in areas where the voluntary organisation Arthritis Care
provided the “challenging arthritis” intervention. This is a
programme for self management of arthritis developed from the
original US model based on social cognitive theory, in which self
efficacy plays an important part (see box A on bmj.com).7 We
identified general practices that belonged to the Medical
Research Council’s research framework and, in areas where this
was not possible, we approached local primary care research
networks. Trained research nurses recruited practice partici-
pants.
Recruitment
We recruited participants between December 2000 and February
2003. Twelve month follow-up for all participants ended in
March 2004.
Figures A and B, figure legends, and boxes 1 and 2 are on bmj.com
Cite this article as: BMJ, doi:10.1136/bmj.38965.375718.80 (published 13 October 2006)
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Participants
Patients were eligible if they were aged 50 or more, had been
clinically diagnosed with osteoarthritis of the hips or knees (or
both) for at least a year, and had had associated pain or
functional disability (or both) during the past month. We
excluded people who had been recommended surgery for
arthritis or who had poor mobility, poor understanding of Eng-
lish, associated neurological signs, or cognitive impairment.
General practitioners identified potential participants from
practice attendees over a six week period. Practices’ computer-
ised records were also searched for relevant osteoarthritis clinical
terms (Read codes) and prescriptions for regular non-steroidal
anti-inflammatory drugs or analgesics. We examined all clinical
records to establish the duration of the diagnosis of osteoarthri-
tis. Research nurses posted study details, a screen for current
symptoms of osteoarthritis, and an invitation to discuss the trial
to potential participants. Patients who met all eligibility criteria
and consented to participate were randomised to one of two
groups.
Randomisation
We used an independent centralised computerised system to
randomise the participants. Practices were stratified by area and
we used minimisation to balance for differences in age and sex.
Research nurses faxed details of consenting participants to the
trial manager, who passed the information on to the randomisa-
tion centre that allocated participants to their experimental
group. The trial manager was the only member of the research
team not blinded to the allocation.
The intervention group received an education booklet and
an invitation to participate in a local challenging arthritis course.
The booklet was designed for the study and incorporated infor-
mation available to the public from Arthritis Care and the
Arthritis Research Campaign.
The control group received only the education booklet. This
reflects standard primary care, where giving written information
is common practice. Research suggests leaflets have substantially
less impact than the self management programme on the
outcomes measured.8
Outcomes were assessed through questionnaires completed
by the participants at entry to the trial before randomisation and
at four and 12 months (box B on bmj.com). All measures were
validated in primary care populations.9–12 The four and 12 month
questionnaires were sent to all participants with a postage paid
return envelope. Non-responders were sent a reminder
questionnaire by recorded delivery. At 12 months, non-
responders were telephoned and given the option of completing
only the primary outcome measure (the short form health
survey, SF-36).
Statistical methods and analysis
Data were double entered and analysed using SPSS for Windows
Release 11.5.0 and SOLAS for missing data analysis version 3.2.
We calculated sample size on the basis of the primary outcome
measure (SF-36). If the dropout rate was 30%, 1000 participants
would be needed to detect a six point difference in SF-36 with
90% power and a 5% two sided significance level, assuming a
standard deviation of 25.13 The arthritis self efficacy scale was an
important secondary measure, and we estimated that 1000 par-
ticipants would allow us to detect a difference of 2.5 points,
assuming a standard deviation of 10.14
We used descriptive statistics to outline the characteristics of
the trial participants. To adjust for baseline scores, we used analy-
sis of covariance to compare outcome between the two groups.15
Assumptions required for this method were found to be valid for
all outcomes. Primary comparisons assessed the effect of the
intervention at 12 months. Analysis was based on intention to
treat. We used imputation techniques to assess the impact of
missing data. Baseline scores were imputed for participants with
missing baseline values, using the technique of “hot decking,”16
based on age, sex, and randomisation group. Once a baseline
score was available, we imputed multiple complete data sets (five)
using a predictive model based approach with ordinary least
squares regression.17 We used the standard complete data
method (analysis of variance) to analyse each imputed data set.
The results were combined using explicit standard formulae to
provide results based on imputation of missing data.
For the multiple imputation analysis we split participants into
those who attended four or more sessions (judged to have
received a clinically significant “dose”18) and those who attended
fewer than four. (The number of sessions attended was unknown
for seven participants, and they were included in the group that
attended fewer than four sessions.) We also undertook a per pro-
tocol analysis of patients who had attended four or more sessions
and for whom full sets of data were available.
All comparisons of outcome scores between intervention
and control groups are presented as the difference in means
after adjusting for baseline differences in the outcome. We used
standard parametric techniques to calculate confidence intervals
for these differences.
Economic evaluation
Service use and cost implications were fully examined in an eco-
nomic evaluation carried out as part of our study. The results of
this will be reported separately.
Results
We approached 2891 people from 74 UK general practices and
recruited 812 participants (figure). Questionnaire response rates
 Patients aged ≥50 diagnosed by their general
practitioner with osteoarthritis of the hips or knees
(or both) invited to take part in the study (n=2891)*
 Patients who attended screening interview (n=922)
 Consented and randomised (n=812)
Unwilling to participate (n=1027)
No response to invitation (n=776)
Ineligible at initial contact (n=166)
Assigned to receive arthritis self
management programme and
education booklet (intervention
arm) (n=406)
Assigned to receive education
booklet only (control arm)
(n=406)
Refused at interview to participate in trial (n=75)
Ineligible at interview (n=35)
Died (n=5)
Withdrew (n=35)
Non-responders (n=72)
Included in primary analysis
(n=406)
*Participants were recruited from 74 UK general practices, of which 57
were from the Medical Research Council's general practice research
framework and 17 from local primary care research networks
Included in primary analysis
(n=406)
Died (n=2)
Withdrew (n=23)
Non-responders (n=56)
Flow of participants through trial
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were 95% at baseline, 80 % at four months, and 76% at 12
months, with no significant differences in response rates between
groups. We found no significant differences in patient character-
istics at baseline between the intervention and control groups
(table 1). The mean age of participants was 68 years, and two
thirds (66%; 510/812) were women. Most participants were
white and owned their homes rather than renting. In the
intervention group more than half (56%; 219/392) attended
four or more sessions, 9% (37/392) attended only one or two
sessions, and 29% (115/392) attended none.
At baseline we found no significant differences between the
groups in outcome variables (table 2). In the intention to treat
analysis with imputation of missing values we found no
significant differences in the primary outcome (SF-36 physical
and mental health scores), but in the intervention group we
found a trend towards improvement on the mental health scale
(table 3; figs A and B on bmj.com).With respect to the secondary
outcomes, we found no significant differences for the three com-
ponents of the WOMAC osteoarthritis index, although the inter-
vention group showed a consistently favourable trend, which was
greater at 12 months than four months.
In the intervention group the anxiety subscore of the hospi-
tal anxiety and depression scale (HADS) was significantly
reduced at 12 months (adjusted difference in means -0.62, 95%
confidence interval − 1.08 to − 0.16). We also found a significant
reduction in the depression subscore at four months ( − 0.40
( − 0.76 to − 0.03), but this was lost by 12 months.We found a sig-
nificant difference between groups for the pain subscore of the
arthritis self efficacy (ASE) scale after four and 12 months (1.63,
0.83 to 2.43; 0.98, 0.07 to 1.89) and for the “other” subscore (1.83,
0.74 to 2.92; 1.58, 0.25 to 2.90).
The two groups did not differ significantly in rates of consul-
tation with a general practitioner at 12 months before the study
or at 12 months’ follow-up. The results of the intention to treat
analysis and the per protocol analysis (those patients who com-
pleted four or more sessions of the intervention and for whom
we had complete data) were similar (table 3).
Discussion
Our trial adds substantially to the literature on self management
of osteoarthritis because of its relatively large size18 and because
participants were recruited from primary care rather than from
outpatient clinics or via advertisements. The intervention had an
impact on the psychological wellbeing of participants. It reduced
anxiety, as measured by the hospital anxiety and depression
scale, and it increased self efficacy—participants were more con-
Table 1 Baseline characteristics of patients in a randomised controlled trial
of self management of arthritis. Values are number (percentage) unless
stated otherwise
Characteristic
Group
Intervention Control
Age
Mean (SD) 68.4 (8.2) 68.7 (8.6)
Sex
Male 151/406 (37) 151/406 (37)
Female 255/406 (63) 255/406 (63)
Accommodation
Owner occupier 323/391 (83) 302/384 (79)
Staying with family or friends 3/391 (<1) 5/384 (1)
Rented accommodation 65/391 (17) 77/384 (20)
Ethnic origin
White 388/390 (100) 382/385 (99)
Black African 0/390 (0) 1/385 (<1)
Black Caribbean 2/390 (<1) 2/385 (1)
Age when left school
Below 16 years 249/390 (64) 259/383 (68)
16 to 18 years 141/390 (36) 124/383 (32)
Higher education
No 281/388 (72) 280/382 (73)
Yes 107/388 (28) 102/382 (27)
Table 2 Mean (SD) baseline results of all outcome measures after “hot
deck” imputation of missing data in randomised controlled trial of self
management of arthritis
Outcome measure
Group
Intervention (n=406) Control (n=406)
Short form 36
Summary physical health 25.4 (10.6) 25.1 (11.7)
Summary mental health 52.2 (10.8) 50.6 (10.6)
WOMAC osteoarthritis index
Pain 8.8 (3.6) 8.7 (3.7)
Stiffness 3.8 (1.6) 3.8 (1.6)
Physical functioning 28.6 (12.3) 29.1 (12.7)
Hospital anxiety and depression scale
Anxiety subscale 7.4 (4.5) 7.2 (4.1)
Depression subscale 5.5 (3.3) 5.5 (3.2)
Arthritis self efficacy scale
Pain 18.9 (6.7) 19.2 (6.4)
Other 25.6 (8.2) 25.7 (7.7)
Table 3 Outcomes of a randomised controlled trial of self management of arthritis
Outcome measure
Adjusted difference in means (95% CI)
4 months 12 months
Intention to treat analysis Per protocol analysis Intention to treat analysis Per protocol analysis
Short form 36
Mental health 0.11 (−1.18 to 1.40) 0.82 (−0.94 to 2.57) 1.35 (−0.03 to 2.74) 1.56 (−0.28 to 3.39)
Physical health 0.22 (−1.50 to 1.94) −0.37 (−2.02 to 1.28) 0.33 (−1.31 to 1.98) 0.24 (−1.63 to 2.11)
WOMAC osteoarthritis index
Pain −0.15 (−0.57 to 0.28) −0.30 (−0.79 to 0.19) −0.33 (−0.78 to 0.13) −0.47 (−1.05 to 0.10)
Stiffness −0.05 (−0.28 to 0.17) −0.12 (−0.36 to 0.11) −0.17 (−0.43 to 0.09) −0.13 (−0.40 to 0.14)
Physical function −1.22 (−2.59 to 0.16) −0.80 (−2.24 to 0.63) −1.17 (−2.84 to 0.50) −0.95 (−2.63 to 0.74)
Hospital anxiety and depression scale
Anxiety −0.36 (−0.76 to 0.05) −0.68 (−1.15 to −0.20)* −0.62 (−1.08 to −0.16)* −0.72 (−1.24 to −0.21)*
Depression −0.40 (−0.76 to −0.03)* −0.57 (−0.96 to −0.18)* −0.41 (−0.82 to 0.01) −0.33 (−0.76 to 0.10)
Arthritis self efficacy scale
Pain 1.63 (0.83 to 2.43)* 2.55 (1.56 to 3.56)* 0.98 (0.07 to 1.89)* 1.43 (0.37 to 2.48)*
Other 1.83 (0.74 to 2.92)* 2.81 (1.74 to 3.87)* 1.58 (0.25 to 2.90)* 1.54 (0.48 to 2.60)*
*Statistically significant.
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fident about managing pain and other arthritis related
symptoms as a result.
Other outcomes, in particular the mental health subscale of
the SF-36, showed a favourable trend in the intervention group,
but this was not statistically significant. These findings indicate
that the intervention improves participants’ ability to manage
their symptoms and leads to a sustained reduction in anxiety, but
that it does not substantially affect physical functioning or levels
of pain experienced. The intervention did not reduce the
number of consultations with a general practitioner; this may be
because the intervention encouraged participants to seek advice
from their general practitioner. Reductions in consultation rates
might arise after the 12 month follow-up, as a result of greater
self efficacy.
Comparison with other studies
We used established and validated clinical measures that have
been used in other studies of osteoarthritis. Many studies of self
management programmes for arthritis have used other outcome
measures, including health behaviours (exercise, management of
cognitive symptoms, communication with doctors, use of
community resources, and management of mental stress) and
health status (fatigue and positive affects). These are usually self
reported measures, which are not always validated, and they have
indicated an increase in desirable patient behaviours, such as
taking more exercise, after the intervention.18 It is not clear
whether these changes have positive and long term effects on
patient behaviour and morbidity. Moreover, only a few studies
report improved quality of life.19 This range of reported
outcomes raises questions about which outcomes are most
meaningful socially and clinically, and what are appropriate
effect sizes.
A clear indication of the clinical efficacy of self management
programmes for arthritis is hard to establish from the literature
because of the variability of previous studies, which were hetero-
geneous in terms of the intervention (group or one to one pro-
grammes, of different lengths), underlying theory (cognitive,
social construct theory, or neither), and methods.18 20 A recent,
comprehensive systematic review of education programmes for
self management of chronic disease found small to moderate
effects for selected outcomes in chronic diseases (such as diabe-
tes and asthma). Education programmes for self management of
arthritis were associated with a trend towards reduced pain and
disability, but the effects were not statistically significant.20
Psychological outcomes were not examined. Some evidence
exists, however, that treating depression in patients with osteoar-
thritis may help reduce the amount of pain experienced and
improve functional status and quality of life.21
Most previous studies involved volunteers, and few
randomised controlled trials have been carried out. A recent
randomised controlled trial of self management programmes for
arthritis that studied US patients with osteoarthritis, rheumatoid
arthritis, or fibromyalgia recruited from primary care showed no
difference in any of the outcomes measured (disability, pain, self
efficacy, mental health, or satisfaction) at four months.6 This was
a small study, however, with a total of 178 participants. Only 12%
of those approached were recruited, and the completed
questionnaire response rate was only 57%.
Strengths and limitations
This was a large randomised controlled trial of the effect of a self
management programme for osteoarthritis in a primary care
population. Although we did not recruit the initial target of 1000
participants, our attrition rate (24% by 12 months) was lower
than the anticipated 30%. Initial sample size calculations were
based on SF-36 and arthritis self efficacy scores. Our data
showed that initial assumptions about the variability of these
measures (standard deviations) were conservative, and thus we
had overestimated the sample size needed. The trial would
almost certainly have identified clinically meaningful differences
in primary outcomes if they existed.
As the study was a pragmatic primary care based trial we
recruited participants who had been diagnosed with osteoarthri-
tis by their general practitioner rather than applying formal
assessment criteria, which are not used in routine general
practice. The sociodemographic data for our participants in
terms of housing status was similar to 2001 UK census data,
apart from a slight predominance of white participants (99.5%)
compared with the national average of 96% for this age group.22
Almost 30% of the intervention group did not attend any
“challenging arthritis” sessions. Telephone interviews with a sub-
group of non-attenders indicated the main reason was timing of
the local group or difficulties with access. Results of the intention
to treat and per protocol analyses suggest that poor attendance
did not affect the final results—results were similar for an inten-
tion to treat analysis of all participants who had been offered the
intervention and those who attended four or more sessions. Such
programmes need to consider how to maximise participation,
and the relatively poor uptake of the intervention is of concern
in terms of the accessibility and acceptability of self management
programmes in primary care.
Our trial results show small positive changes across all
outcomemeasures, but these were statistically significant only for
mental health outcomes and arthritis self management
behaviours. Patients who volunteered for previous studies may
have been more severely affected than those recruited from pri-
mary care for this trial. It is difficult to compare baseline values
with other self management studies because of variability in the
outcome measures used. However, comparison of anxiety and
depression using the hospital anxiety and depression scale shows
higher mean baseline values in a group of UK volunteers studied
than in the primary care patients in our trial.14 Despite this, our
intervention group still showed a significant improvement in
anxiety.
Policy implications
The UK government has been promoting the large scale provi-
sion of the expert patient programme through referral from pri-
mary care before a formal evaluation has been completed,23 and
our results should help inform policy. Our trial indicates that the
intervention can lead to benefits in perceived psychological well-
being, anxiety, and self efficacy for participants with osteoarthri-
tis; however, although these psychological benefits were
statistically significant, the effects were small and their clinical
relevance for the population tested as a whole is unclear. Further
work is needed to establish any predictive factors that might
indicate participants who are most likely to benefit. Larger effects
may be more likely in volunteers with high levels of motivation
and morbidity.
Importantly, despite the enthusiasm of nurses based in the
practices, it was often difficult to recruit patients to a self
management programme similar to that advocated in govern-
ment initiatives to empower patients. This suggests that patients
may not perceive a need for such programmes.
Indications for further research
The main impact of this complex intervention was on
psychological outcomes, but the process by which this was
achieved is unclear. Further research is needed to clarify the
mechanism whereby the intervention can effect change. An
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understanding of how the various components of the
intervention may impact on different outcomes could allow
appropriate targeting of patients to the intervention. This is
important given the heterogeneity of the patient population
receiving a generic self management approach to chronic
disease (www.expertpatients.nhs.uk/).
Conclusions
Our study adds greatly to the literature on self management pro-
grammes for arthritis by reporting findings from a large
randomised controlled trial of patients with osteoarthritis
recruited from primary care and by using established and well
validated outcome measures. Little doubt exists that such
techniques provide some benefit for those with chronic
conditions, but the best way to provide the intervention is
unclear, and insufficient evidence exists to justify a policy of
active recruitment of patients from primary care settings.
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What is already known on this topic
Self management programmes for arthritis tested on US
and UK volunteers indicate benefits to pain, depression,
exercise taken, communication with doctors, and
participants’ perception of their ability to manage the
disease
The government is promoting the widespread provision of
a generic self management programme for chronic disease
through primary care
What this study adds
Participants recruited from UK primary care to a
randomised controlled trial of self management for arthritis
reported reduced symptoms of anxiety and improved self
efficacy in managing symptoms
The intervention had no significant effect on pain, physical
functioning, or primary care contacts at 12 months’
follow-up
These modest benefits do not justify a policy of active
recruitment in primary care
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In this research paper by Marta Buszewicz and colleagues (BMJ 2006;333:879-82,
doi: 10.1136/bmj.38965.375718.80, 28 Oct), the authors meant, but forgot, to
acknowledge Lisa Cotterill,  Gill Dorer, Jeannett Martin, Claire Newland, Gloria
Randall, and Tom Sensky, who are all members of the trial steering committee.
